UMH Properties Valuation
Is UMH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of UMH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: UMH ($19.15) is trading below our estimate of fair value ($32.84)
Significantly Below Fair Value: UMH is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for UMH?
Key metric: As UMH is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is UMH's PS Ratio? | |
|---|---|
| PS Ratio | 6.4x |
| Sales | US$235.20m |
| Market Cap | US$1.54b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 10.2x |
| Enterprise Value/EBITDA | 23.6x |
| PEG Ratio | 3.1x |
Price to Sales Ratio vs Peers
How does UMH's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 5.8x | ||
ELS Equity LifeStyle Properties | 8.9x | 4.4% | US$14.2b |
BHM Bluerock Homes Trust | 1x | n/a | US$186.9m |
AMH American Homes 4 Rent | 8.2x | 5.8% | US$15.8b |
SUI Sun Communities | 5x | 5.2% | US$16.5b |
UMH UMH Properties | 6.4x | 5.3% | US$1.5b |
Price-To-Sales vs Peers: UMH is expensive based on its Price-To-Sales Ratio (6.4x) compared to the peer average (5.8x).
Price to Sales Ratio vs Industry
How does UMH's PS Ratio compare vs other companies in the US Residential REITs Industry?
| 1 Company | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
CLPR Clipper Realty | 0.6x | 7.7% | US$217.06m |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: UMH is expensive based on its Price-To-Sales Ratio (6.4x) compared to the North American Residential REITs industry average (5.9x).
Price to Sales Ratio vs Fair Ratio
What is UMH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 6.4x |
| Fair PS Ratio | 3.2x |
Price-To-Sales vs Fair Ratio: UMH is expensive based on its Price-To-Sales Ratio (6.4x) compared to the estimated Fair Price-To-Sales Ratio (3.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$19.15 | US$21.81 +13.9% | 6.8% | US$25.00 | US$20.00 | n/a | 8 |
| Nov ’25 | US$18.21 | US$21.63 +18.8% | 7.0% | US$25.00 | US$20.00 | n/a | 8 |
| Oct ’25 | US$19.44 | US$21.57 +11.0% | 7.5% | US$25.00 | US$20.00 | n/a | 7 |
| Sep ’25 | US$19.46 | US$21.57 +10.9% | 7.5% | US$25.00 | US$20.00 | n/a | 7 |
| Aug ’25 | US$18.11 | US$18.86 +4.1% | 8.8% | US$21.50 | US$17.00 | n/a | 7 |
| Jul ’25 | US$16.04 | US$18.50 +15.3% | 8.3% | US$21.50 | US$17.00 | n/a | 6 |
| Jun ’25 | US$15.12 | US$18.50 +22.4% | 8.3% | US$21.50 | US$17.00 | n/a | 6 |
| May ’25 | US$15.80 | US$18.50 +17.1% | 9.9% | US$21.50 | US$16.00 | n/a | 6 |
| Apr ’25 | US$15.94 | US$18.50 +16.1% | 9.9% | US$21.50 | US$16.00 | n/a | 6 |
| Mar ’25 | US$15.86 | US$18.60 +17.3% | 9.4% | US$20.00 | US$16.00 | n/a | 5 |
| Feb ’25 | US$15.10 | US$18.60 +23.2% | 9.4% | US$20.00 | US$16.00 | n/a | 5 |
| Jan ’25 | US$15.32 | US$18.60 +21.4% | 9.4% | US$20.00 | US$16.00 | n/a | 5 |
| Dec ’24 | US$14.55 | US$18.60 +27.8% | 9.4% | US$20.00 | US$16.00 | n/a | 5 |
| Nov ’24 | US$13.88 | US$19.70 +41.9% | 7.5% | US$22.00 | US$17.50 | US$18.21 | 5 |
| Oct ’24 | US$14.02 | US$19.70 +40.5% | 7.5% | US$22.00 | US$17.50 | US$19.44 | 5 |
| Sep ’24 | US$14.95 | US$19.75 +32.1% | 6.8% | US$22.00 | US$17.50 | US$19.46 | 6 |
| Aug ’24 | US$16.54 | US$19.33 +16.9% | 8.3% | US$22.00 | US$17.00 | US$18.11 | 6 |
| Jul ’24 | US$15.98 | US$19.29 +20.7% | 7.7% | US$22.00 | US$17.00 | US$16.04 | 7 |
| Jun ’24 | US$15.34 | US$19.29 +25.7% | 7.7% | US$22.00 | US$17.00 | US$15.12 | 7 |
| May ’24 | US$15.24 | US$19.31 +26.7% | 7.9% | US$22.00 | US$16.50 | US$15.80 | 8 |
| Apr ’24 | US$14.79 | US$20.00 +35.2% | 5.0% | US$22.00 | US$19.00 | US$15.94 | 8 |
| Mar ’24 | US$15.79 | US$20.75 +31.4% | 4.7% | US$22.00 | US$19.00 | US$15.86 | 8 |
| Feb ’24 | US$18.32 | US$20.88 +13.9% | 4.4% | US$22.00 | US$19.00 | US$15.10 | 8 |
| Jan ’24 | US$16.10 | US$21.44 +33.2% | 9.7% | US$26.50 | US$19.00 | US$15.32 | 8 |
| Dec ’23 | US$17.41 | US$21.50 +23.5% | 10.3% | US$26.50 | US$19.00 | US$14.55 | 7 |
| Nov ’23 | US$17.51 | US$24.00 +37.1% | 13.4% | US$28.00 | US$19.00 | US$13.88 | 7 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Innovative Industrial Properties
US$3.0b
A self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities.
IIPR
US$105.30
7D
2.2%
1Y
31.6%
Rayonier
US$4.5b
Rayonier is a leading timberland real estate investment trust with assets located in some of the most productive softwood timber growing regions in the United States and New Zealand.
RYN
US$30.15
7D
0.1%
1Y
-3.0%
Chatham Lodging Trust
US$435.6m
Chatham Lodging Trust (“we,” “us” or the “Company”) was formed as a Maryland real estate investment trust on October 26, 2009.
CLDT
US$8.78
7D
-5.0%
1Y
-10.9%